RxSearch

NDC properties for NDC 9 54436-275

NDC item 54436027501

NDC 954436-275
NDC 1054436-275-01
NDC Item54436027501
packaging1 SYRINGE in 1 CARTON (54436-275-01) / .5 mL in 1 SYRINGE (54436-275-03)
DCSACIII
FDA SPL set id760387
LabelerAntares Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2018-11-15
Marketing statusACTIVE
NDANDA209863

NDC item 54436027502

NDC 954436-275
NDC 1054436-275-02
NDC Item54436027502
packaging0.5 mL in 1 SYRINGE
DCSACIII
FDA SPL set id760387
LabelerAntares Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2018-11-15
Marketing statusACTIVE
NDANDA209863

NDC item 54436027503

NDC 954436-275
NDC 1054436-275-03
NDC Item54436027503
packaging0.5 mL in 1 SYRINGE
DCSACIII
FDA SPL set id760387
LabelerAntares Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2018-11-15
Marketing statusACTIVE
NDANDA209863

NDC item 54436027504

NDC 954436-275
NDC 1054436-275-04
NDC Item54436027504
packaging4 SYRINGE in 1 CARTON (54436-275-04) / .5 mL in 1 SYRINGE (54436-275-02)
DCSACIII
FDA SPL set id760387
LabelerAntares Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2018-11-15
Marketing statusACTIVE
NDANDA209863

NDC item 54436027505

NDC 954436-275
NDC 1054436-275-05
NDC Item54436027505
packaging1 SYRINGE in 1 CARTON (54436-275-05) / .5 mL in 1 SYRINGE (54436-275-02)
DCSACIII
FDA SPL set id760387
LabelerAntares Pharma, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryNDA
Marketing effective time low2018-11-15
Marketing statusACTIVE
NDANDA209863